Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Rheumatoid Arthritis”

150 trials

Showing 20 of 150 results

Testing effectiveness (Phase 2)Study completedNCT00595413
What this trial is testing

Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)

Who this might be right for
Rheumatoid Arthritis
EMD Serono 311
Large-scale testing (Phase 3)Study completedNCT04512001
What this trial is testing

MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 604
Post-approval studies (Phase 4)Study completedNCT02187055
What this trial is testing

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Who this might be right for
Rhematoid Arthritis
Pfizer 1,152
Large-scale testing (Phase 3)Study completedNCT03789292
What this trial is testing

Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 648
Testing effectiveness (Phase 2)Looking for participantsNCT06972446
What this trial is testing

Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AbbVie 180
Not applicableStudy completedNCT03387423
What this trial is testing

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,459
Large-scale testing (Phase 3)Study completedNCT00891020
What this trial is testing

Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 886
Post-approval studies (Phase 4)Study completedNCT00996203
What this trial is testing

Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 201
Large-scale testing (Phase 3)Study completedNCT00535782
What this trial is testing

The Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 132
Post-approval studies (Phase 4)Study completedNCT04928066
What this trial is testing

The Efficacy and Safety of Tofacitinib (TF) With Iguratimod (IGU) on RA

Who this might be right for
Arthritis, Rheumatoid
Qilu Hospital of Shandong University 100
Large-scale testing (Phase 3)Study completedNCT02706873
What this trial is testing

Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,002
Large-scale testing (Phase 3)Study completedNCT01194414
What this trial is testing

Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,262
Large-scale testing (Phase 3)Study completedNCT03052322
What this trial is testing

MSB11022 in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH 288
Testing effectiveness (Phase 2)Study completedNCT02015520
What this trial is testing

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
CSL Behring 143
Large-scale testing (Phase 3)Study completedNCT00106574
What this trial is testing

Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,220
Not applicableActive Not RecruitingNCT04871919
What this trial is testing

Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Alfasigma S.p.A. 1,304
Testing effectiveness (Phase 2)Study completedNCT01373151
What this trial is testing

Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
CSL Behring 418
Large-scale testing (Phase 3)Study completedNCT02955212
What this trial is testing

A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 338
Testing effectiveness (Phase 2)WithdrawnNCT02795299
What this trial is testing

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bird Rock Bio, Inc.
Early research (Phase 1)Looking for participantsNCT07207954
What this trial is testing

Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lifordi Immunotherapeutics, Inc. 176
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation